The Division of Pediatric Diabetes and Endocrinology is known for its exemplary educational program and research efforts.
Our mission is to improve the health of all diabetes and endocrinology patients — especially children in Missouri — through patient-centered care.
- Excellence: We pursue the highest goals and accept the sacrifices and responsibilities required to achieve our best possible performance.
- Respect: We nurture free and open discourse, listen to new ideas and value diverse perspectives and talents.
- Service: We put forth our most diligent efforts on behalf of our patients, learners, stakeholders and partners.
- Integrity: We commit to honesty, truthfulness and authenticity in our relationships and activities.
- Responsibility: We exhibit a strong sense of duty, stewardship and accountability to each other and to the public.
- Innovation: We pursue an ongoing, collaborative process of discovery and translate knowledge for the benefit and service of society.
- Compassion: We relate to others in a caring, empathic manner and strive to prevent and relieve human suffering.
- Inclusion: We promote diversity and convey a sense of belonging, respect and value for all persons.
Robert L. Jackson, MD, served as the first Chief of Pediatric Endocrinology at the MU School of Medicine. He emphasized how controlling blood sugars in Type 1 diabetes would help prevent complications. At the time, Dr. Jackson’s views were unconventional — yet they eventually resulted in the Diabetes Control and Complications Trial (DCCT) as well as him receiving the Banting Award, which is the highest award from the American Diabetes Association.
David Goldstein, MD, was the second chief of our division. His contribution to the diabetes field was the development of the HbA1c with Randy Little, PhD, and Jack London. The University of Missouri pathology lab sets the standard nationally and internationally for the HbA1c. Dr. Goldstein also participated in the DCCT trial as well as its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC).
Today, Bert Bachrach, MD, serves as the third Chief of Pediatric Endocrinology. His interests lie within managing patients with glycogen storage disease. He sits as chair on the Association of Glycogen Storage Disease Scientific Advisory Board, and he treats patients from as far away as Oklahoma and Kansas.
Find information for patients.